Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Trijardy XR for type 2 diabetes

Jan. 28, 2020

Anerem approved in Japan for general anesthesia

Jan. 24, 2020

Japanese approval for Corectim ointment for atopic dermatitis

Jan. 24, 2020

FDA grants accelerated approval of Tazverik for epithelioid sarcoma

Jan. 24, 2020

Dotinurad receives Japanese approval for hyperuricemia

Jan. 24, 2020

Japanese approval of Dinagest for dysmenorrhea

Jan. 23, 2020

Tepezza approved in the U.S. for thyroid eye disease

Jan. 22, 2020

Emrok and Emrok O approved in India for acute bacterial skin and skin structure infections

Jan. 21, 2020

FDA approves Polaryx's IND for PLX-200 in LINCL

Jan. 21, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...